Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.60 |
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | ATM | Q13315 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 4/20 | 0.53 |
| ▸ | RAB9A | P51151 | 4/20 | 0.53 |
| ▸ | TP53 | P04637 | 3/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | PKM | P14618 | 2/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL336206 | 1.00 | SMN1; SMN2 (0.61) | SMN1; SMN2KDM4EALDH1A1LMNAATM | |
| Iodide SCHEMBL27898886 | 1.00 | SMN1; SMN2 (0.61) | SMN1; SMN2KDM4EALDH1A1LMNAATM | |
| SCHEMBL353890 | 0.98 | SMN1; SMN2 (0.63) | SMN1; SMN2KDM4EALDH1A1LMNAATM | |
| Bromide SCHEMBL5318089 | 0.96 | SMN1; SMN2 (0.61) | SMN1; SMN2KDM4EALDH1A1LMNAATM | |
| Ammonia Solution, Strong SCHEMBL19182582 | 0.96 | SMN1; SMN2 (0.61) | SMN1; SMN2KDM4EALDH1A1LMNAATM | |
| Hydrochloric Acid SCHEMBL20291495 | 0.94 | SMN1; SMN2 (0.59) | SMN1; SMN2KDM4EALDH1A1LMNAATM | |
| Formamide SCHEMBL17938372 | 0.87 | SMN1; SMN2 (0.52) | SMN1; SMN2KDM4EALDH1A1LMNAATM | |
| SCHEMBL27562084 | 0.87 | SMN1; SMN2 (0.52) | SMN1; SMN2KDM4EALDH1A1LMNAATM | |
| SCHEMBL1171430 | 0.82 | MEN1 (0.69) | SMN1; SMN2KDM4EALDH1A1LMNAATM | |
| SCHEMBL29354143 | 0.82 | ALDH1A1 (0.50) | SMN1; SMN2KDM4EALDH1A1LMNAATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8097756-B2 | Process for producing carboxylic acid anhydrides | CHINA PETROCHEMICAL DEVELOPMENT CORPORATION (TW) | 2012-01-17 | — | — | US | claimed |
| US-20100145098-A1 | PROCESS FOR PRODUCING CARBOXYLIC ACID ANHYDRIDES | CHINA PETROCHEMICAL DEVELOPMENT CORPORATION (TW) | 2010-06-10 | — | — | US | claimed |
| US-8097756-B2 | Process for producing carboxylic acid anhydrides | CHINA PETROCHEMICAL DEVELOPMENT CORPORATION (TW) | 2012-01-17 | — | — | US | disclosed |
| US-20100145098-A1 | PROCESS FOR PRODUCING CARBOXYLIC ACID ANHYDRIDES | CHINA PETROCHEMICAL DEVELOPMENT CORPORATION (TW) | 2010-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100145098-A1 | PROCESS FOR PRODUCING CARBOXYLIC ACID ANHYDRIDES | CA4, CA9, CA7 | SMN1; SMN2 2703/4885KDM4E 947/4885ALDH1A1 200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.